News
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
23hon MSN
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
22hon MSN
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback